Autres langues Lombard Medical, Inc.

Actions

EVARF

KYG555981094

Temps Différé OTC Markets Autres places de cotation 02:10:00 29/11/2023			Varia. 5j.	Varia. 1 janv.
0,000001 ^USD	-.--%		-.--%	-.--%

2017

Lombard Medical, Inc. annonce des résultats non audités pour le troisième trimestre clos le 30 septembre 2017 ; fournit des prévisions de résultats pour le quatrième trimestre 2017 et l'exercice 2018.

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Lombard Medical, Inc.(NasdaqCM:EVAR) dropped from NASDAQ Composite Index	08/11/17
Lombard Medical, Inc. Announces Unaudited Earnings Results for the Third Quarter Ended September 30, 2017; Provides Earnings Guidance for the Fourth Quarter of 2017 and Fiscal Year 2018	31/10/17
Lombard Medical, Inc. Announces Full Commercial Launch of Japan of its New Low-Profile IntelliFlex LP Delivery System for the Aorfix AAA System	26/09/17
Lombard Medical, Inc. Appoints Jonathan Hornsby as Vice President, Sales & Marketing	20/09/17
Lombard Medical, Inc. Announces Resignation of William J. Kullback as Chief Financial Officer, Effective May 5, 2017	28/04/17
Lombard Medical, Inc. Appoints Kurt Lemvigh as CEO	20/04/17
Lombard Medical, Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2016; Reports Impairment-Goodwill and Long-Lived Intangibles for the Fourth Quarter of 2016	18/04/17
Simon Hubbert Steps Down from Lombard Medical, Inc. as CEO	18/04/17
Lombard Medical, Inc. and MicroPort Scientific Corporation Finalize Strategic Partnership Agreements	03/04/17
Lombard Medical, Inc. Announces Board Changes	19/12/16
Lombard Medical, Inc. and MicroPort Scientific Corporation Announce Strategic Partnership	19/12/16
Lombard Medical, Inc. announced that it has received $15 million in funding from MicroPort NeuroTech Co., Ltd., MicroPort NeuroTech CHINA Corp. Limited	18/12/16
Lombard Medical, Inc. Announces Positive Long-Term Data for Aorfix™	05/12/16
Lombard Medical, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2016	27/10/16
Lombard Medical, Inc. Wins GBP 202.7 Million Multiple Awardees Contract	26/10/16
Invesco Intends to Engage in Discussions with Lombard Medical	15/09/16
Lombard Medical, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2016	22/08/16
Lombard Medical Seeks Strategic Alternatives	22/08/16
Lombard Medical, Inc. Announces CE Mark Approval for IntelliFlex™ LP Delivery System for the Aorfix™ Abdominal Aortic Aneurysm Endovascular Stent Graft	20/06/16
Lombard Medical, Inc. Plans to Conduct 1,000 Patient Global Registry to Evaluate New Altura Endograft System	16/06/16

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Lombard Medical, Inc.

Actions

EVARF

KYG555981094

Autres langues

Filtres